HIV/AIDS IN THE BLACK COMMUNITY:

A SOCIAL DETERMINANT ANALYSIS AND POLICY RECOMMENDATIONS

 

Jay Carrington Chunn, Ph.D

Policy Monograph

 

August, 2008

 

 

Published by the National Center

 for Health Behavioral Change e-Press©

Location: Urban Medical Institute /Morgan State University

 2600 Liberty Heights Avenue

Baltimore, MD 21215

www.nchbc.org

 

 

Funding for this monograph provided by the Joint Center for Political and Economic Studies, Washington, DC: Subcontract number P0093824-694-6012

 

 

 

CONTENTS

 

 

Introduction                                                                                                             pg 3

HIV/AIDS in Black America                                                                                  pg 4

Existing National Policy                                                                                          pg 5

Proposed National Policy                                                                                        pg 15

Social Determinants of HIV/AIDS Policy for African Americans                      pg 19

Policy Recommendations                                                                                        pg 26

Conclusion                                                                                                                pg 36

Bibliography & Notes                                                                                              pg 39

About the Author: Consult www.nchbc.org for bio under about us

 

 

 

 

 

 

 

 

 

 

 

 

 

 

INTRODUCTION

           

            On June 5, 2006, the public health community recognized a difficult 25th anniversary. On that date in 1981, a rare form of pneumonia cystitis was diagnosed and discovered in a handful of white homosexual men in San Francisco, California. Shortly after this discovery, the victims succumbed to the symptoms of the condition that is known as Acquired Immune Deficiency Syndrome (AIDS). This puzzled the medical and scientific communities, who used their resources to determine that AIDS was not just a variation of a common disease, but a unique and deadly epidemic that had the potential to wreak havoc on populations and communities. This disease was a slow-moving virus that attacked the immune system of its victims until they were left vulnerable and powerless to fight off opportunistic infections that would eventually kill them. The growing epidemic was identified as similar to a disease that had been the cause of death for many in Africa as early as the 1950s. Scientists discovered that this disease was spread through contact with body fluids of infected individuals. This contact included sexual transmission and the receipt of infected blood through transfusions. They also found that Human Immunodeficiency Virus (HIV) was the initial condition that eventually progressed to AIDS. Those who found that they were infected with the disease were aware that their life would soon end. That fear was compounded by the prejudice, harassment, and scorn that were heaped upon them by biased people who did not understand the disease.

            What started as a disease affecting a handful of gay men turned into a pandemic of epic proportions and soon began to infect both homosexuals and heterosexuals. It was clear that HIV/AIDS had the potential to spiral out of control if it was not stopped and/or contained. However, the United States government was slow to respond to the growing AIDS problem. Lawmakers had to be convinced to enact policies to study and prevent this disease. Little attention was paid to this disease in the 1980s, when it was first recognized. That lack of attention allowed the disease to progress to the point that it is today.

As the affected population changes, it is necessary to reassess policies, re-engage policymakers, and enact prevention as well as treatment programs. To that end, this monograph examines current HIV/AIDS policies and proposed policy initiatives. It then identifies the social determinants that should drive HIV/AIDS policymaking for the African American community, including politics, economics, gender, age, and geography. Finally, it concludes with recommendations for new policies and directions that will better serve African Americans.

 

HIV/AIDS IN BLACK AMERICA

 

            African Americans are disproportionately affected by HIV/AIDS infection. They have an AIDS diagnosis rate nearly 10 times higher than that of whites.[i] In 2004, they made up 12.2 percent of the U.S. population, but 49.3 percent of the AIDS cases estimated to be diagnosed that year.[ii] For black adults, the AIDS rate (the number of people living with AIDS per 100,000 population) was 72.1, while it was only 17.1 for the total U.S. population.[iii] The rate at which black women were diagnosed with AIDS in 2004 was 23 times the rate for white women, while the rate for black men was eight times that of white men.[iv]

HIV infection among African Americans due to intravenous drug use is especially common. In Baltimore City, for example, statistical analysis suggests that as high as 75 percent of all new cases are related to drug abuse.[v] Many of these drug users are identified as heroin addicts as well as intravenous drug users who use crack and/or cocaine. Drug addicts spread the disease to their partners primarily through sexual contact and needle-sharing. Female addicts acquire and spread the disease because they often prostitute themselves in exchange for drugs. The issue of drugs and HIV/AIDS is not exclusive to the African American community, but it is a crucial factor that affects the spread of the disease among this population. Indeed, the lack of sufficient substance abuse treatment programs and the very low number of prevention programs have been cited as reasons for the spread of HIV/AIDS among African Americans.[vi]

            By 2003, there was widespread recognition of the changing face and demographics of HIV/AIDS. That year, the Ryan White CARE Act appropriated $104 million to be spent by the Centers for Disease Control and Prevention (CDC) to study the disparity between people of color and whites. However, the following year, despite the fact that no conclusive evidence had been obtained to explain and address the racial/ethnic disparity, there was no increase to the CDC to continue this study.[vii] In this way, the foremost organization for researching disease and prevention was prohibited from increasing its efforts to generate research that would help prevent HIV/AIDS in African Americans and other people of color. In addition to the need for further such research on the issues surrounding HIV/AIDS disparities between people of color and whites, national policies pertaining to the disease need to be assessed to determine their impact on African Americans. We now turn to an examination of these policies.

 



[i] National AIDS Treatment Advocacy Project, “HIV and Black Women” (2006), http://www.natap.org/2006/HIV/031506_03.htm (accessed February 13, 2008).

 

[ii] Ibid.; HIV/AIDS Bureau, Health Resources and Services Administration, U.S. Department of Health and Human Services, “African-Americans and HIV/AIDS in the United States,” http://hab.hrsa.gov/History/AfricanAmericans/ (accessed February 20, 2007).

 

[iii] HIV/AIDS Bureau, “African-Americans and HIV/AIDS in the United States.”

 

[iv] Ibid.

 

[v] Jay Carrington Chunn, The Health Behavioral Change Imperative (New York, NY: Springer Publishing Company, 2002).

 

[vi] Christopher Lance Coleman, “The Transmission of HIV/AIDS among African American Intravenous Drug Users: Implication for Public Health Policy,” The ABNF Journal (Sep/Oct 2004), http://findarticles.com/p/articles/mi_m0MJT/is_5_15/ai_n6276689/pg_1.

 

[vii] National Alliance of State and Territorial AIDS Directors, “Minority HIV/AIDS Report Language,” http://www.sfaf.org/documents/minority-hiv-aids-initiative-report-language.pdf (accessed June 21, 2006).